you are here: HomeNewsTrendsHealth

COVID-19 vaccination drive: How states plan to immunise those with hesitations

States are planning to roll out awareness campaigns and are reaching out to religious groups and minority institutions to encourage hesitating healthcare workers to get vaccinated against COVID-19.

January 21, 2021 / 10:14 AM IST
Representative image: AP

Representative image: AP

The Union Health Ministry has advised states to run awareness programmes to ensure that healthcare workers take the COVID-19 vaccine, The Economic Times reported. This came amid low immunisation figures in several states.

Based on this advice, state governments came up with different strategies to tackle people’s hesitation towards getting inoculated. The strategies include appeals from state health ministers and administrative staff that the COVID-19 vaccines are safe, the news report suggested. Some states have also identified ‘COVID warriors’ who will be vaccinated to help dispel fears.

Follow our LIVE blog for the latest updates of the coronavirus pandemic

“We have identified our top doctors and every day some well-known doctors would take the vaccine to give a message to our healthcare workers that these vaccines are safe,” Bihar health minister Mangal Pandey told the newspaper.

In Gujarat, all district collectors have also been asked to reach out to religious groups and minority institutions.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

According to the report, Tamil Nadu – which has one of the lowest COVID-19 vaccination coverages in India so far – is seeking help from social influencers and religious leaders to ensure healthcare workers take the vaccine.

West Bengal’s Health Secretary HS Nigam told the newspaper that launching a "no side effects" campaign would not be enough and effort would be made to clear doubts that the health workers have.

Read - COVID-19 vaccination drive: States receive additional Covishield doses

The Drugs Controller General of India (DCGI) has approved Covishield, produced by the Serum Institute of India (SII) and Bharat Biotech’s Covaxin for restricted emergency use. However, beneficiaries will not be able to choose between the two jabs at this stage. Many have raised apprehensions about Covaxin as it is still in a phase-3 clinical trial.

COVID-19 Vaccine Tracker: All you need to know about manufacturing and pricing

As of January 20, India had reported more than 1.05 crore confirmed COVID-19 cases. The death toll from the outbreak in the country stood at over 1.52 lakh. While more than 1.02 crore patients had recovered, 1.97 lakh cases remained ‘active’. Globally, more than 9.62 crore individuals have been infected by the virus and over 20.62 lakh people have died so far.

A speedy rollout of vaccines is being seen as the best way to curb the spread of COVID-19 and restore normalcy in the pandemic-battered global economy. Many countries have already vaccinated a large number of people from high-risk groups.

A total of 7.86 lakh beneficiaries had been vaccinated for COVID-19 in 14,119 sessions till the evening of January 20, according to a provisional report of the Union Health Ministry.

Click here for Moneycontrol’s full coverage of the coronavirus pandemic
Moneycontrol News
first published: Jan 21, 2021 10:14 am

stay updated

Get Daily News on your Browser